BACKGROUND AND PURPOSE National guidelines recommend imaging within 25 minutes of emergency department arrival and intravenous tissue-type plasminogen activator within 60 minutes of emergency department arrival for patients with acute stroke. In 2007, we implemented a new institutional acute stroke care model to include 10 best practices and evaluated the effect of this intervention on improvin...

BACKGROUND Although best practices have been developed for achieving door-to-needle (DTN) times ≤60 minutes for stroke thrombolysis, critical DTN process failures persist. We sought to compare these failures in the Emergency Department at an academic medical center and a community hospital. METHODS AND RESULTS Failure modes effects and criticality analysis was used to identify system and proc...

Background: We aim to assess the effect of simultaneous acute code stroke activation(ACSA) in patients undergoing reperfusion therapies emergency department on home time at 90 days. Methods: assessed ACSA over 20 months from QuICR(Quality Improvement and Clinical Research Alberta Stroke Program) Registry. defined Simultaneous therapy as, within 60 min arrival any patient receiving intravenous t...

BACKGROUND AND PURPOSE Timely administration of intravenous tissue-type plasminogen activator (IV tPA) is associated with improved outcomes for acute ischemic stroke; yet, developing processes to consistently provide prompt treatment remains a challenge. We developed and evaluated a simple quality improvement intervention designed to improve door-to-needle (DTN) times for resident-led Code Stro...

As computer use increasingly influence everyday life, we need to complement our knowledge of the computer as a technology for creating fast and efficient tools, with other perspectives on information technology. We describe Slow Technology , technology aimed at promoting moments of reflection and mental rest. Taking the design programme of Slow Technology as our starting point, we have explored...

Neutropenic sepsis is a life-threatening condition with mortality rates reported to range between 2 and 21% in adults. It can occur following chemotherapy treatment, due to disease (such as haematological conditions affecting the bone marrow) and in patients on disease-modifying agents (such as patients receiving methotrexate for rheumatoid arthritis). Appropriate emergency treatment is essenti...